HydroMARK Plus versus HydroMARK: comparing biopsy site marker retrieval and surgeon satisfaction

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares the retrieval success of the newer HydroMARK Plus biopsy site marker to the existing HydroMARK in patients who already have biopsy clips and are scheduled for surgical removal using SCOUT localization. The primary outcome is the rate of successful marker retrieval at surgery, and the secondary outcome is surgeon satisfaction with retrieval. Eligible adult patients (18–90 years) with biopsy clips scheduled for SCOUT-localized surgery are enrolled at The Kirklin Clinic, with exclusions for inmates and non-English speakers. The University of Alabama at Birmingham is the lead sponsor and the device is provided in collaboration with Mammotome, with procedures and data collection performed at the single study site.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with biopsy clips scheduled for surgery with SCOUT localization

Exclusion Criteria:

* Patients who didn't have surgery, patients younger than 18 years old
* Patients older than 90 years old
* Inmates
* Non-English speakers

Where it's running

• The Kirklin Clinic
  Birmingham, Alabama, United States Recruiting

Study contacts

• Principal investigator: Ceren Yalniz, MD — University of Alabama at Birmingham
• Study coordinator: Quenteeria Mooney
• Email: qmooney@uabmc.edu
• Phone: 205-996-1082

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-powered mobile app to support chemotherapy for breast cancer

  A mobile app in Arabic uses AI to help women undergoing chemotherapy see if it can improve symptom control and medication adherence compared with standard care.

  Recruiting University of Baghdad · Baghdad · NCT07273812

• Cryoablation for small breast tumors (SIX)

  This study will test whether cryoablation works as well as standard breast surgery for people with small (≤2.0 cm), unifocal early-stage breast cancer and will compare direct costs over one year.

  Recruiting Phase 3 Hospital do Coracao · São Paulo, São Paulo and 1 other locations · NCT06839001

• Predicting outcomes for advanced breast cancer patients treated with CDK4/6 inhibitors and endocrine therapy

  This study is trying to see how well different CDK4/6 inhibitors combined with hormone therapy work for people with advanced breast cancer and how safe they are.

  Recruiting at 24 sites Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Aviano and 23 other locations · NCT06805812

• Blood test to identify patients at high risk for breast cancer

  This study is testing a new blood test that uses advanced technology to see if it can help identify women at high risk for breast cancer.

  Recruiting at 2 sites EXoPERT · Honolulu, Hawaii and 2 other locations · NCT06672302

• Using tart cherry juice to prevent nerve damage from chemotherapy in breast cancer patients

  This study is testing if drinking tart cherry juice can help prevent nerve damage in breast cancer patients receiving chemotherapy.

  Recruiting Phase 2 University of California, Davis · Sacramento, California · NCT06268665

• A program to improve lifestyle behaviors in young women with breast cancer

  This study tests a program designed to help young women with breast cancer make healthy lifestyle changes to improve their overall well-being and treatment outcomes.

  Recruiting Instituto Nacional de Cancerologia de Mexico · México · NCT06090747

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.